Skip to main content
Top
Published in: Cancer Causes & Control 12/2010

01-12-2010 | Original paper

Light at night and breast cancer risk: results from a population-based case–control study in Connecticut, USA

Authors: Qian Li, Tongzhang Zheng, Theodore R. Holford, Peter Boyle, Yawei Zhang, Min Dai

Published in: Cancer Causes & Control | Issue 12/2010

Login to get access

Abstract

Objective

To investigate the potential association between domestic exposure to light at night (LAN) and the risk of human breast cancer.

Methods

A case–control study of female breast cancer was conducted in Connecticut. A total of 363 incident breast cancer cases and 356 age frequency-matched controls were interviewed using a standardized, structured questionnaire to obtain information on sleeping patterns and bedroom light environment. Odds ratios (ORs) and 95% confidence intervals (CIs) were estimated by unconditional multivariate logistic regression.

Results

A non-significantly increased risk of breast cancer was observed among postmenopausal women for those keeping lights on while sleeping (OR = 1.4, 95% CI 0.7, 2.7), those who reported mainly sleeping in the daytime (OR = 1.4, 95% CI 0.5, 4.3), and those not drawing the curtains/window shades while sleeping at night (OR = 1.2, 95% CI 0.8, 1.9).

Conclusion

The results from this study suggest a potential increased risk of breast cancer associated with domestic exposure to LAN. Further studies with larger sample size are needed to confirm the results.
Literature
1.
go back to reference Straif K, Baan R, Grosse Y et al (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 8:1065–1066CrossRefPubMed Straif K, Baan R, Grosse Y et al (2007) Carcinogenicity of shift-work, painting, and fire-fighting. Lancet Oncol 8:1065–1066CrossRefPubMed
2.
go back to reference Hansen J (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12:74–77CrossRefPubMed Hansen J (2001) Increased breast cancer risk among women who work predominantly at night. Epidemiology 12:74–77CrossRefPubMed
3.
go back to reference Kolstad HA (2008) Nightshift work and risk of breast cancer and other cancers—a critical review of the epidemiologic evidence. Scand J Work Environ Health 34:5–22PubMed Kolstad HA (2008) Nightshift work and risk of breast cancer and other cancers—a critical review of the epidemiologic evidence. Scand J Work Environ Health 34:5–22PubMed
4.
go back to reference Lie JA, Roessink J, Kjaerheim K (2006) Breast cancer and night work among Norwegian nurses. Cancer Causes Control 17:39–44CrossRefPubMed Lie JA, Roessink J, Kjaerheim K (2006) Breast cancer and night work among Norwegian nurses. Cancer Causes Control 17:39–44CrossRefPubMed
5.
go back to reference Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES (2005) Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 41:2023–2032CrossRefPubMed Megdal SP, Kroenke CH, Laden F, Pukkala E, Schernhammer ES (2005) Night work and breast cancer risk: a systematic review and meta-analysis. Eur J Cancer 41:2023–2032CrossRefPubMed
6.
go back to reference Schernhammer ES, Laden F, Speizer FE et al (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst 93:1563–1568CrossRefPubMed Schernhammer ES, Laden F, Speizer FE et al (2001) Rotating night shifts and risk of breast cancer in women participating in the nurses’ health study. J Natl Cancer Inst 93:1563–1568CrossRefPubMed
7.
go back to reference Schernhammer ES, Kroenke CH, Laden F, Hankinson SE (2006) Night work and risk of breast cancer. Epidemiology 17:108–111CrossRefPubMed Schernhammer ES, Kroenke CH, Laden F, Hankinson SE (2006) Night work and risk of breast cancer. Epidemiology 17:108–111CrossRefPubMed
8.
go back to reference Schwartzbaum J, Ahlbom A, Feychting M (2007) Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 33:336–343PubMed Schwartzbaum J, Ahlbom A, Feychting M (2007) Cohort study of cancer risk among male and female shift workers. Scand J Work Environ Health 33:336–343PubMed
9.
go back to reference Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7:197–204CrossRefPubMed Tynes T, Hannevik M, Andersen A, Vistnes AI, Haldorsen T (1996) Incidence of breast cancer in Norwegian female radio and telegraph operators. Cancer Causes Control 7:197–204CrossRefPubMed
10.
go back to reference Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557–1562CrossRefPubMed Davis S, Mirick DK, Stevens RG (2001) Night shift work, light at night, and risk of breast cancer. J Natl Cancer Inst 93:1557–1562CrossRefPubMed
11.
go back to reference O’Leary ES, Schoenfeld ER, Stevens RG et al (2006) Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol 164:358–366CrossRefPubMed O’Leary ES, Schoenfeld ER, Stevens RG et al (2006) Shift work, light at night, and breast cancer on Long Island, New York. Am J Epidemiol 164:358–366CrossRefPubMed
12.
go back to reference Stevens RG (2009) Working against our endogenous circadian clock: breast cancer and electric lighting in the modern world. Mutat Res 680:106–108PubMed Stevens RG (2009) Working against our endogenous circadian clock: breast cancer and electric lighting in the modern world. Mutat Res 680:106–108PubMed
13.
go back to reference Stevens RG (2009) Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol 38:963–970CrossRefPubMed Stevens RG (2009) Light-at-night, circadian disruption and breast cancer: assessment of existing evidence. Int J Epidemiol 38:963–970CrossRefPubMed
14.
go back to reference Stevens RG (2009) Electric light causes cancer? Surely you’re joking, Mr. Stevens. Mutat Res 682:1–6CrossRefPubMed Stevens RG (2009) Electric light causes cancer? Surely you’re joking, Mr. Stevens. Mutat Res 682:1–6CrossRefPubMed
15.
go back to reference Hansen J (2001) Light at night, shiftwork, and breast cancer risk. J Natl Cancer Inst 93:1513–1515CrossRefPubMed Hansen J (2001) Light at night, shiftwork, and breast cancer risk. J Natl Cancer Inst 93:1513–1515CrossRefPubMed
16.
go back to reference Zheng T, Holford TR, Mayne ST et al (2000) Exposure to electromagnetic fields from use of electric blankets and other in-home electrical appliances and breast cancer risk. Am J Epidemiol 151:1103–1111PubMed Zheng T, Holford TR, Mayne ST et al (2000) Exposure to electromagnetic fields from use of electric blankets and other in-home electrical appliances and breast cancer risk. Am J Epidemiol 151:1103–1111PubMed
17.
18.
go back to reference Stevens RG, Blask DE, Brainard GC et al (2007) Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect 115:1357–1362CrossRefPubMed Stevens RG, Blask DE, Brainard GC et al (2007) Meeting report: the role of environmental lighting and circadian disruption in cancer and other diseases. Environ Health Perspect 115:1357–1362CrossRefPubMed
19.
go back to reference Vujovic N, Davidson AJ, Menaker M (2008) Sympathetic input modulates, but does not determine, phase of peripheral circadian oscillators. Am J Physiol Regul Integr Comp Physiol 295:R355–R360PubMed Vujovic N, Davidson AJ, Menaker M (2008) Sympathetic input modulates, but does not determine, phase of peripheral circadian oscillators. Am J Physiol Regul Integr Comp Physiol 295:R355–R360PubMed
20.
go back to reference Hoffman AE, Zheng T, Yi CH et al (2010) The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev Res (Phila Pa) 3:539–548 Hoffman AE, Zheng T, Yi CH et al (2010) The core circadian gene Cryptochrome 2 influences breast cancer risk, possibly by mediating hormone signaling. Cancer Prev Res (Phila Pa) 3:539–548
21.
go back to reference Goldman BD (2001) Mammalian photoperiodic system: formal properties and neuroendocrine mechanisms of photoperiodic time measurement. J Biol Rhythms 16:283–301CrossRefPubMed Goldman BD (2001) Mammalian photoperiodic system: formal properties and neuroendocrine mechanisms of photoperiodic time measurement. J Biol Rhythms 16:283–301CrossRefPubMed
22.
23.
go back to reference Everson CA (1993) Sustained sleep deprivation impairs host defense. Am J Physiol 265:R1148–R1154PubMed Everson CA (1993) Sustained sleep deprivation impairs host defense. Am J Physiol 265:R1148–R1154PubMed
24.
go back to reference Schernhammer ES, Hankinson SE (2005) Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 97:1084–1087CrossRefPubMed Schernhammer ES, Hankinson SE (2005) Urinary melatonin levels and breast cancer risk. J Natl Cancer Inst 97:1084–1087CrossRefPubMed
25.
go back to reference Schernhammer ES, Berrino F, Krogh V et al (2008) Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 100:898–905CrossRefPubMed Schernhammer ES, Berrino F, Krogh V et al (2008) Urinary 6-sulfatoxymelatonin levels and risk of breast cancer in postmenopausal women. J Natl Cancer Inst 100:898–905CrossRefPubMed
Metadata
Title
Light at night and breast cancer risk: results from a population-based case–control study in Connecticut, USA
Authors
Qian Li
Tongzhang Zheng
Theodore R. Holford
Peter Boyle
Yawei Zhang
Min Dai
Publication date
01-12-2010
Publisher
Springer Netherlands
Published in
Cancer Causes & Control / Issue 12/2010
Print ISSN: 0957-5243
Electronic ISSN: 1573-7225
DOI
https://doi.org/10.1007/s10552-010-9653-z

Other articles of this Issue 12/2010

Cancer Causes & Control 12/2010 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine